NDC 51662-1503-01 - LIDOCAINE HCl AND EPINEPHRINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1503
- Requested NDC
- 51662-1503-01
- Package NDCs from labels
- 51662-1503-1, 51662-1503-2, 51662-1503-3, 51662-1503-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-06-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE HCl AND EPINEPHRINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-06-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1503-1 | LIDOCAINE HCl AND EPINEPHRINE | 30 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 30 | 7 | |
| 51662-1503-2 | LIDOCAINE HCl AND EPINEPHRINE | 30 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 30 | 7 | |
| 51662-1503-2 | LIDOCAINE HCl AND EPINEPHRINE | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 7 | |
| 51662-1503-3 | LIDOCAINE HCl AND EPINEPHRINE | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1503 | LIDOCAINE HCL AND EPINEPHRINE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 4 package rows | 20240224_a09613b2-4337-5b52-e053-2995a90ab74b.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Saline | NASAL | WALGREEN COMPANY | 147e45c8-1e71-4c06-89f1-42e9f9683366 | 2025-12-01 | Warnings | 451W47IQ8X |
| Sterile Saline Mist Meijer | SODIUM CHLORIDE | Meijer, Inc. | 445c8f4f-0519-0764-e063-6294a90a8b39 | 2025-12-01 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Brookfield Pharmaceuticals, LLC. | e824ba5b-3289-5ad4-e053-2995a90acc20 | 2025-11-27 | Warnings, Adverse reactions | V13007Z41A |
| Walgreen Maximum strength pain relieving cleansing | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | WALGREENS CO. | 9a0443a2-f1a9-482d-b5ee-abe983e4ae32 | 2025-11-26 | Warnings | V13007Z41A |
| Walgreen Saline | NASAL | WALGREENS CO. | ee264d8b-0bb2-472a-907c-6a6291f154cd | 2025-11-26 | Warnings | 451W47IQ8X |
| Walgreen Pain Relieving Fragrance Free | LIDOCAINE HYDROCHLORIDE | WALGREENS CO. | 62c50ded-3fc9-4f65-9bfb-1144ed2e36b4 | 2025-11-26 | Warnings | V13007Z41A |
| Walgreens | FIRST AID ANTISEPTIC | Walgreens | ae731d28-8530-4dd0-aef7-b25f784b4777 | 2025-11-26 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | 82b377ee-0e3e-4cb9-a644-f45434c21cca | 2025-11-26 | Warnings, Adverse reactions | V13007Z41A |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | XF417D3PSL | |
| Thyroid-Adrenal | ADRENALINUM, THYROIDINUM, ALOE, CALC. CARB., CHELIDONIUM MAJUS, CONIUM, GRAPHITES, IODIUM, LACHESIS, LYCOPODIUM, LYCOPUS VIRGINICUS, PHYTOLACCA, RHUS TOXICODENDRON, SILICEA, SPONGIA, ECHINACEA | Newton Laboratories, Inc. | b597504a-c667-225c-e053-2a95a90ac704 | 2025-11-25 | Warnings | YKH834O4BH |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Natural Eyes Floaters Relief | CHELIDONIUM, EUPHRASIA, KALI SULPH, NATRUM MURIATICUM, PHOSPHORUS, PHYSOSTIGMA, SEPIA, SILICEA | TRP Company | 445dc831-195e-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42df73b0-20ee-d1aa-e063-6294a90aa275 | 2025-11-21 | Warnings, Adverse reactions | V13007Z41A |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.